TGFB1 and Alzheimer disease: The TGFβ/Smad signaling pathway is believed to be involved in a wide spectrum of physiological and pathological mechanisms that are implicated in several neurological disorders, including Parkinson's disease [14], multiple sclerosis [15], and AD [16].